- BBS Pharmaceuticals Contact
- contact@bbspharmaceuticals.com
BBS Pharmaceuticals News
[display-posts include_excerpt=”true” excerpt_length=”20″ image_size=”thumbnail” wrapper=”div” wrapper_class=”display-posts-listing image-left”]
July 18, 2020
BBS Pharmaceuticals, a licensed cultivatotor and manufacturer of medicinal cannabis products would like toto congratulate Minister David Littleproud and the Australian Parliament in passing the Export […]
June 18, 2020
It has been a busy and productive start of the second quarter here at BBS Pharmaceuticals. We had the honour toto welcome local Member of Hammond, […]
June 11, 2020
It has been a busy and incredibly productive start of the week here at BBS as we are entering the second half of the year. This […]
April 30, 2020
Australia has published a framework for new CBD regulations as it considers relaxing its narcotics scheduling of cannabidiol toto make it available over the counter in […]
April 23, 2020
Michael Kromwyk has been appointed Head of Sales and Marketing at BBS Pharmaceuticals with responsibility for brand and marketing programs, sales strategy, growing product sales, partnering […]
April 23, 2020
These are challenging times as the world responds toto the coronavirus outbreak and sets a path toto recovery. First off, our hearts go out toto anyone […]
April 14, 2020
As various phases of legalisation come intoto effect in different parts of Australia, the country’s cannabis market is expected toto break through the barrier of US$1.5 […]
March 27, 2020
The Australian Senate Committee has revealed their recommendations from the inquiry ‘Current barriers toto patient access toto medicinal cannabis in Australia’. In its 118-page long document, […]
March 12, 2020
In the coming months, the TGA will expand the number of quality audits of medicinal cannabis products imported or supplied under the Special Access Scheme (SAS) […]